M&T Bank’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
M&T Bank's ADPT Position: Q2 2026 in Review
M&T Bank increased its Adaptive Biotechnologies (ADPT) stake by 2.2% in Q2 2026, buying an estimated $6.83K and bringing the position to 21,100 shares worth $453K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.
M&T Bank first reported a position in ADPT in Q2 2020 and has held it in 4 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- M&T Bank held 21,100 shares of Adaptive Biotechnologies worth $453K as of Q2 2026.
- M&T Bank bought 446 Adaptive Biotechnologies shares in Q2 2026, an estimated $6.83K.
- Adaptive Biotechnologies made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1256 holding.
- M&T Bank first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 4 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.